Michael King

NIH announces end to funding for animal-only studies - Drug Discovery and Development Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.

This is extraordinarily dangerous and will slow academic biomedical research and drug development. A total ban is on the horizon. www.drugdiscoverytrends.com/nih-announce...

The line between “no Medicaid for you” and “the only option for access to ‘health care’ if you don’t have insurance is participating in risky, untested interventions” is a short one.

Animal models are the bridge from bench to bedside.

Public comment on this new "no animal only studies" is open here:

www.fda.gov/news-events/...

It closes next Monday.

I'm pleased to announce that CMBE now has an impact factor of 5.0! And don't forget, there's no publishing fee.

AIMBE has launched our new Citizen Advocate for Science Letter: takeaction.io/aimbe/scienc...

We ask the broader scientific community to widely share this letter (✍️ <1 minute) with friends, family, and other concerned citizens to urge their elected officials to protect biomedical research funding 👇

I'm pleased to share this nicely done video that captures how special the Rice partnership with the Texas Medical Center is for biomedical researchers... 🔬 🧪 🏙️

YouTube video by Rice University Health Innovations in the Rice TMC Ecosystem ENRICH

And here is a direct link to the video!

m.youtube.com/watch?v=CWdD...

Check out this awesome recap story and video on our recent Health Innovations symposium…
Thank you to everyone who helped to make this event a great success!
@riceenrich.bsky.social

news.rice.edu/news/2025/en...

AIMBE has posted a public statement on the impact of federal policy changes on biomedical research: aimbe.org/advocate/wri...

Above, we have also developed an advocacy letter for members of the medical & biological engineering community to send to their congressional representatives on this matter.

Funding delays and policy changes are disrupting labs, jeopardizing jobs, and putting the future of science and biomedical engineering at risk. Trainees and early-career researchers are being hit hardest. @aimbe-official.bsky.social is taking action.

Read our statement & send a letter to Congress

A screen capture of the Friends of NIBIB (FoNIBIB) landing page on our website.

AIMBE is proud to announce the formation of the Friends of National Institute of Biomedical Imaging and Bioengineering (FoNIBIB) coalition! @friendsofnibib.bsky.social

FoNIBIB advocates for NIBIB initiatives by promoting public awareness of its scientific & training programs.

friendsofnibib.org

If your institution/organization is interested in joining FoNIBIB, please fill out our interest form here: aimbe.wufoo.com/forms/q1td4w...

Follow @friendsofnibib.bsky.social to learn more about coalition activities and NIBIB-related updates.

Researchers, your voice is more important now than ever.

We welcome institutions and scientific organizations with a vested interest in medical and biological engineering to join the Friends of NIBIB (FoNIBIB) coalition!

We look forward to working with you all to champion the important research and innovations supported by NIBIB.

friendsofnibib.org

A flyer of the AIMBE Public Policy Institute for Rising Leaders in Washington, D.C.

Registration is now open for AIMBE's Public Policy Institute on October 27-28, 2025 in Washington, DC! Students and trainees in BME can expect 2 days of science and policy training and talks by top Washington insiders.

Travel awards are also available!

Register now here: aimbe.org/institute

A screen capture of the AIMBE advocacy webpage with 3 advocacy letters outlined in red boxes: STEM Training Pipeline, NIH & NSF Indirect Cost Caps, and FY26 Funding.

🚨 AIMBE is calling on the biomedical research community to take a minute to send our 3 new advocacy letters urging Congress to:

1. Protect the STEM Training Pipeline (e.g., NIH MOSAIC, T32s, MARC, etc.)

2. Oppose Indirect Cost Caps

3. Support Research Funding in FY2026

aimbe.org/advocate/wri...

Thanks for attending…. Looking forward to a great Day2!

What a packed first day of great talks, panel discussions and networking at the Rice—TMC Health Innovations symposia! Truly at the hub of innovations, research and education! Thank you @riceenrich.bsky.social and @profmikeking.bsky.social for hosting and organizing this event!

Aloha brother, welcome to Bluesky!
#academicsky #okinawan #uchinanchu

AIMBE is among the 48 societies and nearly 100,000 scientists/experts who recently signed onto @ucsusa.bsky.social's letter calling on Congress to protect the future of science 👇

The full letter is available here: ucs-documents.s3.us-east-1.amazonaws.com/science-netw...

AIMBE is among the 52 societies and organizations who signed onto @aibsbiology.bsky.social's letter to congressional leaders urging them to protect U.S. scientific research and integrity in response to recent executive actions 👇

The full letter is available here: www.aibs.org/assets/colle...

We do life-saving research at Rice. NIH cuts could end that. Proposed cuts to the National Institutes of Health's funding to universities could threaten critical research, including cancer detection and gene therapies.

Here's how NIH cuts could jeopardize our life-saving research at Rice University | Opinion

www.houstonchronicle.com/opinion/outl...

Join us at the "Health Innovations in the Rice-TMC Ecosystem" symposium for a series of presentations on Innovations in Cancer Research
April 24-25
Helix Park's TMC3 Collaborative Building
Tickets: bit.ly/3DaBGrR About the event: bit.ly/4kcZP1I

Congratulations to King Lab PhD student Natalie Curry, who won a poster prize at the NCI Tissue Engineering Collaborative Annual Investigators Meeting, for her study on the effect of fluid shear stress on macrophage polarization! Outdoor session in Miami, fun! 🔬☀️

Pub alert for a paper written in collaboration with Mike King's lab where we used focused ultrasound to mechanically stimulate prostate tumor cells in vivo, enhancing apoptosis. Congratulations to our brilliant team members, Abigail Fabiano and Malachy Newman, for their exceptional work!

Excited to share our new paper using Focused Ultrasound to mechanically stimulate prostate tumor cells in vivo, now published in Advanced Science! #OpenAccess
Great collab with @cfcaskey.bsky.social
Congrats to Abby Fabiano and Malachy Newman 🔊
news.rice.edu/news/2025/ri...

ASPR COVID-19 Testing NAVIGATION

Did you know: your government has 160 million non-expired COVID-19 tests warehoused, and you are entitled to receive 4 more kits shipped to your address free of charge? Just order at:
covidtests.gov
…they might get destroyed for no good reason, so stock up and be safe

Congratulations to @neuroamyo.bsky.social, one of our inaugural participants in the AIMBE Emerging Leaders Program, on receiving a Sloan Research Fellowship! 🥳

We now have >100 advocates signed up for our #AIMBE2025 Congressional Visits this March 31!

Thank you to our Fellows, Emerging Leaders, and other members for making this AIMBE's largest Hill Day to date 💪🔬🧪

Registration for our Annual Event still remains open: annualevent.aimbe.org

AIMBE has developed a new advocacy letter on the changes to NIH indirect cost rates: aimbe.org/advocate/wri...

We urge the broader biomedical research community to customize this letter (<1 minute) to contact your congressional representatives about the severe consequences of this new policy 👇

Take action now. NIH’s 15% indirect cost cap threatens research institutions, jobs, and innovation. Customize & send AIMBE’s advocacy letter to urge Congress to stop this harmful policy. Your voice matters!